JP2006504717A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504717A5 JP2006504717A5 JP2004541991A JP2004541991A JP2006504717A5 JP 2006504717 A5 JP2006504717 A5 JP 2006504717A5 JP 2004541991 A JP2004541991 A JP 2004541991A JP 2004541991 A JP2004541991 A JP 2004541991A JP 2006504717 A5 JP2006504717 A5 JP 2006504717A5
- Authority
- JP
- Japan
- Prior art keywords
- linear
- alkyl
- branched
- alkenyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41613402P | 2002-10-03 | 2002-10-03 | |
| PCT/US2003/031080 WO2004031148A1 (en) | 2002-10-03 | 2003-10-02 | Piperazine and piperidine derivatives for treatment of neurological diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006504717A JP2006504717A (ja) | 2006-02-09 |
| JP2006504717A5 true JP2006504717A5 (https=) | 2006-10-12 |
Family
ID=32069937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004541991A Pending JP2006504717A (ja) | 2002-10-03 | 2003-10-02 | 神経学的疾患の処置のためのピペラジンおよびピペラジン誘導体 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20040180880A1 (https=) |
| EP (1) | EP1546103B1 (https=) |
| JP (1) | JP2006504717A (https=) |
| KR (1) | KR20050047132A (https=) |
| CN (1) | CN100395236C (https=) |
| AT (1) | ATE425967T1 (https=) |
| AU (1) | AU2003299145A1 (https=) |
| CA (1) | CA2500672A1 (https=) |
| DE (1) | DE60326742D1 (https=) |
| ES (1) | ES2324293T3 (https=) |
| MX (1) | MXPA05003471A (https=) |
| NO (1) | NO20052153L (https=) |
| PL (1) | PL376149A1 (https=) |
| RU (1) | RU2005113247A (https=) |
| TW (1) | TW200533653A (https=) |
| WO (1) | WO2004031148A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7393656B2 (en) * | 2001-07-10 | 2008-07-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for risk stratification |
| GB0508319D0 (en) | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| US20080306087A1 (en) * | 2005-08-08 | 2008-12-11 | Astrazeneca Ab | Therapeutic Agents |
| US7943622B2 (en) | 2006-06-06 | 2011-05-17 | Cornerstone Therapeutics, Inc. | Piperazines, pharmaceutical compositions and methods of use thereof |
| US8853215B2 (en) | 2009-04-16 | 2014-10-07 | Takeda Pharmaceutical Company Limited | Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes |
| RU2486918C1 (ru) * | 2011-10-25 | 2013-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ стимулирования восстановления периферической иннервации тканей с помощью векторных конструкций |
| ES2765738T3 (es) | 2015-11-02 | 2020-06-10 | Janssen Pharmaceutica Nv | Compuesto de [1,2,4]triazolo[1,5-a]pirimidin-7-ilo |
| MX385576B (es) | 2016-11-02 | 2025-03-18 | Janssen Pharmaceutica Nv | Derivados de [1,2,4]triazol[1,5-a]pirimidina como inhibidores de pde2 |
| AU2017353313C1 (en) | 2016-11-02 | 2022-06-09 | Janssen Pharmaceutica Nv | (1,2,4)triazolo(1,5-a)pyrimidine compounds as PDE2 inhibitors |
| CA3038916A1 (en) | 2016-11-02 | 2018-05-11 | Janssen Pharmaceutica Nv | [1,2,4]triazolo[1,5-a]pyrimidine compounds as pde2 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2597100A1 (fr) * | 1986-01-21 | 1987-10-16 | Nippon Shinyaku Co Ltd | Derives du pyroglutamide |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| US5780484A (en) * | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
| US5811434A (en) * | 1996-11-13 | 1998-09-22 | Vertex Pharmacueticals Incorporated | Methods and compositions for stimulating neurite growth |
| US5721256A (en) | 1997-02-12 | 1998-02-24 | Gpi Nil Holdings, Inc. | Method of using neurotrophic sulfonamide compounds |
| AU766579B2 (en) * | 1997-08-29 | 2003-10-16 | Vertex Pharmaceuticals Incorporated | Compounds possessing neuronal activity |
| US6331537B1 (en) * | 1998-06-03 | 2001-12-18 | Gpi Nil Holdings, Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| US6264991B1 (en) * | 1998-08-18 | 2001-07-24 | Southern Research Institute | Compositions and methods for treating intracellular infections |
| HUP0301391A3 (en) * | 2000-02-11 | 2010-03-29 | Vertex Pharma | Piperazine and piperidine derivatives pharmaceutical compositions containing them and their use |
| US20040034019A1 (en) * | 2002-08-08 | 2004-02-19 | Ronald Tomlinson | Piperazine and piperidine derivatives |
-
2003
- 2003-10-02 US US10/677,631 patent/US20040180880A1/en not_active Abandoned
- 2003-10-02 ES ES03756899T patent/ES2324293T3/es not_active Expired - Lifetime
- 2003-10-02 WO PCT/US2003/031080 patent/WO2004031148A1/en not_active Ceased
- 2003-10-02 JP JP2004541991A patent/JP2006504717A/ja active Pending
- 2003-10-02 CN CNB2003801041723A patent/CN100395236C/zh not_active Expired - Fee Related
- 2003-10-02 EP EP03756899A patent/EP1546103B1/en not_active Expired - Lifetime
- 2003-10-02 KR KR1020057005779A patent/KR20050047132A/ko not_active Withdrawn
- 2003-10-02 AT AT03756899T patent/ATE425967T1/de not_active IP Right Cessation
- 2003-10-02 CA CA002500672A patent/CA2500672A1/en not_active Abandoned
- 2003-10-02 RU RU2005113247/04A patent/RU2005113247A/ru not_active Application Discontinuation
- 2003-10-02 AU AU2003299145A patent/AU2003299145A1/en not_active Abandoned
- 2003-10-02 MX MXPA05003471A patent/MXPA05003471A/es not_active Application Discontinuation
- 2003-10-02 PL PL03376149A patent/PL376149A1/xx not_active Application Discontinuation
- 2003-10-02 DE DE60326742T patent/DE60326742D1/de not_active Expired - Lifetime
-
2004
- 2004-04-05 TW TW093109385A patent/TW200533653A/zh unknown
-
2005
- 2005-05-02 NO NO20052153A patent/NO20052153L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6528533B2 (en) | Azo amino acids derivatives | |
| US6849630B2 (en) | Cyclized amino acid derivatives | |
| EP1546103B1 (en) | Piperazine and piperidine derivatives for treatment of neurological diseases | |
| JP2006504717A5 (https=) | ||
| US6660748B2 (en) | Bicyclic derivatives | |
| US6949655B2 (en) | Acyclic piperidine derivatives | |
| US20030144253A1 (en) | Acyclic and cyclic amine derivatives | |
| US6552041B2 (en) | Cyclized amide derivatives | |
| US20020123493A1 (en) | Cyclic amine derivatives | |
| US6677359B2 (en) | N-substituted glycine derivatives | |
| US20020111347A1 (en) | Amino-alkyl derivatives | |
| US20020123492A1 (en) | Beta-amino acid derivatives | |
| AU2002344734A1 (en) | Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage | |
| US20050065339A1 (en) | Amino-alkyl derivatives |